{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:28:46Z","timestamp":1787020126079,"version":"build-2736575974"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,6,29]],"date-time":"2023-06-29T00:00:00Z","timestamp":1687996800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,6,29]],"date-time":"2023-06-29T00:00:00Z","timestamp":1687996800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cardiovasc Disord"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Preserved ratio impaired spirometry (PRISm) is a subtype of pulmonary function abnormality which is characterized by a proportional reduction in non-obstructive expiratory lung volume. Currently, no studies have shown a relationship between PRISm and mortality in myocardial infarction (MI) survivors.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      We used cohort data from U.S. adults who attended the National Health and Nutrition Examination Survey (NHANES) from 2007 to 2012. According to the ratio of forced expiratory volume in the first second (FEV\n                      <jats:sub>1<\/jats:sub>\n                      ) to forced vital capacity (FVC), we divided lung function into normal spirometry (FEV\n                      <jats:sub>1<\/jats:sub>\n                      \/ FVC)\u2009\u2265\u200970%, FEV\n                      <jats:sub>1<\/jats:sub>\n                      \u2009\u2265\u200980%), PRISm (FEV\n                      <jats:sub>1<\/jats:sub>\n                      \/FVC\u2009\u2265\u200970%, FEV\n                      <jats:sub>1<\/jats:sub>\n                      \u2009&lt;\u200980%) and obstructive spirometry (FEV\n                      <jats:sub>1<\/jats:sub>\n                      \/FVC\u2009&lt;\u200970%). Cox regression was used to estimate the correlation between lung functions and mortality among MI patients. Kaplan-Meier survival curves compared the prognosis of MI with three different lung functions. We further verify the stability of the results by sensitivity analysis.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      411 subjects were included in our research. The mean follow-up time for the study was 105 months. Compared with normal spirometry, PRISm was significantly correlated with a greater relative risk for all-cause mortality (adjust HR 3.41, 95% confidence interval [95%CI]: 1.76\u20136.60,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.001) and cardiovascular mortality (adjust HR 13.9, 95%CI: 2.60\u201374.6,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.002). PRISm remains more correlated with all-cause mortality (adjust HR 2.73, 95%CI: 1.28\u20135.83,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.009) relative to obstructive spirometry. The results are basically stable after sensitivity analysis. Kaplan-Meier survival curves showed that patients with PRISm tended to have the lowest survival during the follow-up period.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>PRISm is an independent risk factor for all-cause and cardiovascular mortality in MI survivors. The presence of PRISm was associated with a significantly higher risk of all-cause mortality compared with obstructive spirometry.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12872-023-03352-2","type":"journal-article","created":{"date-parts":[[2023,6,29]],"date-time":"2023-06-29T13:02:00Z","timestamp":1688043720000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["The relationship between preserved ratio impaired spirometry and mortality in the myocardial infarction survivors: a population-based cohort study"],"prefix":"10.1186","volume":"23","author":[{"given":"Dan","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhishen","family":"Ruan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shen","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shunchao","family":"Xuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hengyi","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,6,29]]},"reference":[{"issue":"20","key":"3352_CR1","doi-asserted-by":"publisher","first-page":"1908","DOI":"10.1161\/CIRCULATIONAHA.117.030798","volume":"136","author":"E Puymirat","year":"2017","unstructured":"Puymirat E, Simon T, Cayla G, et al. Acute myocardial infarction: changes in patient characteristics, management, and 6-Month Outcomes over a period of 20 years in the FAST-MI program (French Registry of Acute ST-Elevation or Non-ST-Elevation myocardial infarction) 1995 to 2015. Circulation. 2017;136(20):1908\u201319. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.117.030798.","journal-title":"Circulation"},{"issue":"6","key":"3352_CR2","doi-asserted-by":"publisher","first-page":"1952","DOI":"10.1378\/chest.127.6.1952","volume":"127","author":"DD Sin","year":"2005","unstructured":"Sin DD, Wu L, Man SFP. The relationship between reduced lung function and cardiovascular mortality: a population-based study and a systematic review of the literature. Chest. 2005;127(6):1952\u20139. https:\/\/doi.org\/10.1378\/chest.127.6.1952.","journal-title":"Chest"},{"issue":"6","key":"3352_CR3","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1111\/j.1365-2796.2006.01718.x","volume":"260","author":"G Engstr\u00f6m","year":"2006","unstructured":"Engstr\u00f6m G, Hedblad B, Janzon L. Reduced lung function predicts increased fatality in future cardiac events. A population-based study. J Intern Med. 2006;260(6):560\u20137. https:\/\/doi.org\/10.1111\/j.1365-2796.2006.01718.x.","journal-title":"J Intern Med"},{"issue":"1","key":"3352_CR4","doi-asserted-by":"publisher","first-page":"58","DOI":"10.4187\/respcare.07712","volume":"66","author":"A Schwartz","year":"2021","unstructured":"Schwartz A, Arnold N, Skinner B, et al. Preserved ratio impaired spirometry in a spirometry database. Respir Care. 2021;66(1):58\u201365. https:\/\/doi.org\/10.4187\/respcare.07712.","journal-title":"Respir Care"},{"key":"3352_CR5","doi-asserted-by":"publisher","first-page":"h286","DOI":"10.1136\/bmj.h286","volume":"350","author":"R Varraso","year":"2015","unstructured":"Varraso R, Chiuve SE, Fung TT, et al. Alternate healthy eating Index 2010 and risk of chronic obstructive pulmonary disease among US women and men: prospective study. BMJ. 2015;350:h286. https:\/\/doi.org\/10.1136\/bmj.h286.","journal-title":"BMJ"},{"key":"3352_CR6","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1186\/s12931-014-0089-y","volume":"15","author":"ES Wan","year":"2014","unstructured":"Wan ES, Castaldi PJ, Cho MH, et al. Epidemiology, genetics, and subtyping of preserved ratio impaired spirometry (PRISm) in COPDGene. Respir Res. 2014;15:89. https:\/\/doi.org\/10.1186\/s12931-014-0089-y.","journal-title":"Respir Res"},{"issue":"10","key":"3352_CR7","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1513\/AnnalsATS.201803-184OC","volume":"15","author":"M Jankowich","year":"2018","unstructured":"Jankowich M, Elston B, Liu Q, et al. Restrictive spirometry pattern, Cardiac structure and function, and Incident Heart failure in African Americans. The Jackson Heart Study. Ann Am Thorac Soc. 2018;15(10):1186\u201396. https:\/\/doi.org\/10.1513\/AnnalsATS.201803-184OC.","journal-title":"Ann Am Thorac Soc"},{"issue":"22","key":"3352_CR8","doi-asserted-by":"publisher","first-page":"2287","DOI":"10.1001\/jama.2021.20939","volume":"326","author":"ES Wan","year":"2021","unstructured":"Wan ES, Balte P, Schwartz JE, et al. Association between preserved ratio impaired spirometry and clinical outcomes in US adults. JAMA. 2021;326(22):2287\u201398. https:\/\/doi.org\/10.1001\/jama.2021.20939.","journal-title":"JAMA"},{"issue":"5","key":"3352_CR9","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1164\/rccm.202110-2302OC","volume":"206","author":"Y Washio","year":"2022","unstructured":"Washio Y, Sakata S, Fukuyama S, et al. Risks of mortality and airflow limitation in japanese individuals with preserved ratio impaired spirometry. Am J Respir Crit Care Med. 2022;206(5):563\u201372. https:\/\/doi.org\/10.1164\/rccm.202110-2302OC.","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"3352_CR10","doi-asserted-by":"publisher","first-page":"1901217","DOI":"10.1183\/13993003.01217-2019","volume":"55","author":"SRA Wijnant","year":"2020","unstructured":"Wijnant SRA, De Roos E, Kavousi M, et al. Trajectory and mortality of preserved ratio impaired spirometry: the Rotterdam Study. Eur Respir J. 2020;55(1):1901217. https:\/\/doi.org\/10.1183\/13993003.01217-2019.","journal-title":"Eur Respir J"},{"issue":"2","key":"3352_CR11","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/S2213-2600(21)00369-6","volume":"10","author":"DH Higbee","year":"2022","unstructured":"Higbee DH, Granell R, Davey Smith G, Dodd JW. Prevalence, risk factors, and clinical implications of preserved ratio impaired spirometry: a UK Biobank cohort analysis. Lancet Respir Med. 2022;10(2):149\u201357. https:\/\/doi.org\/10.1016\/S2213-2600(21)00369-6.","journal-title":"Lancet Respir Med"},{"issue":"3","key":"3352_CR12","doi-asserted-by":"publisher","first-page":"00178","DOI":"10.1183\/23120541.00178-2021","volume":"7","author":"CH Shah","year":"2021","unstructured":"Shah CH, Reed RM, Liang Y, Zafari Z. Association between lung function and future risks of diabetes, asthma, myocardial infarction, hypertension and all-cause mortality. ERJ Open Res. 2021;7(3):00178\u20132021. https:\/\/doi.org\/10.1183\/23120541.00178-2021.","journal-title":"ERJ Open Res"},{"issue":"9596","key":"3352_CR13","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1016\/S0140-6736(07)61602-X","volume":"370","author":"E von Elm","year":"2007","unstructured":"von Elm E, Altman DG, Egger M, et al. The strengthening the reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet. 2007;370(9596):1453\u20137. https:\/\/doi.org\/10.1016\/S0140-6736(07)61602-X.","journal-title":"Lancet"},{"issue":"2","key":"3352_CR14","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1183\/09031936.05.00034805","volume":"26","author":"MR Miller","year":"2005","unstructured":"Miller MR, Hankinson J, Brusasco V, et al. Standardisation of spirometry. Eur Respir J. 2005;26(2):319\u201338. https:\/\/doi.org\/10.1183\/09031936.05.00034805.","journal-title":"Eur Respir J"},{"issue":"1","key":"3352_CR15","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1164\/ajrccm.159.1.9712108","volume":"159","author":"JL Hankinson","year":"1999","unstructured":"Hankinson JL, Odencrantz JR, Fedan KB. Spirometric reference values from a sample of the general U.S. population. Am J Respir Crit Care Med. 1999;159(1):179\u201387. https:\/\/doi.org\/10.1164\/ajrccm.159.1.9712108.","journal-title":"Am J Respir Crit Care Med"},{"issue":"6","key":"3352_CR16","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1183\/09031936.00080312","volume":"40","author":"PH Quanjer","year":"2012","unstructured":"Quanjer PH, Stanojevic S, Cole TJ, et al. Multi-ethnic reference values for spirometry for the 3-95-yr age range: the global lung function 2012 equations. Eur Respir J. 2012;40(6):1324\u201343. https:\/\/doi.org\/10.1183\/09031936.00080312.","journal-title":"Eur Respir J"},{"issue":"9","key":"3352_CR17","doi-asserted-by":"publisher","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","volume":"150","author":"AS Levey","year":"2009","unstructured":"Levey AS, Stevens LA, Schmid CH, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150(9):604\u201312. https:\/\/doi.org\/10.7326\/0003-4819-150-9-200905050-00006.","journal-title":"Ann Intern Med"},{"issue":"1","key":"3352_CR18","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1186\/s12872-019-1058-7","volume":"19","author":"PJ Kennel","year":"2019","unstructured":"Kennel PJ, Kneifati-Hayek J, Bryan J, et al. Prevalence and determinants of hyperpolypharmacy in adults with heart failure: an observational study from the National Health and Nutrition Examination Survey (NHANES). BMC Cardiovasc Disord. 2019;19(1):76. https:\/\/doi.org\/10.1186\/s12872-019-1058-7.","journal-title":"BMC Cardiovasc Disord"},{"issue":"1","key":"3352_CR19","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1186\/s12872-023-03147-5","volume":"23","author":"T Fan","year":"2023","unstructured":"Fan T, Su D. Interaction effects between sleep disorders and depression on heart failure. BMC Cardiovasc Disord. 2023;23(1):132. https:\/\/doi.org\/10.1186\/s12872-023-03147-5.","journal-title":"BMC Cardiovasc Disord"},{"key":"3352_CR20","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.2147\/NSS.S319675","volume":"13","author":"J Li","year":"2021","unstructured":"Li J, Covassin N, Bock JM, et al. Excessive daytime sleepiness and Cardiovascular Mortality in US adults: a NHANES 2005\u20132008 Follow-Up study. Nat Sci Sleep. 2021;13:1049\u201359. https:\/\/doi.org\/10.2147\/NSS.S319675.","journal-title":"Nat Sci Sleep"},{"issue":"3","key":"3352_CR21","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1378\/chest.12-0938","volume":"143","author":"JD Maclay","year":"2013","unstructured":"Maclay JD, MacNee W. Cardiovascular disease in COPD: mechanisms. Chest. 2013;143(3):798\u2013807. https:\/\/doi.org\/10.1378\/chest.12-0938.","journal-title":"Chest"},{"issue":"1","key":"3352_CR22","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1139\/y04-116","volume":"83","author":"DD Sin","year":"2005","unstructured":"Sin DD, Man SFP. Chronic obstructive pulmonary disease: a novel risk factor for cardiovascular disease. Can J Physiol Pharmacol. 2005;83(1):8\u201313. https:\/\/doi.org\/10.1139\/y04-116.","journal-title":"Can J Physiol Pharmacol"},{"issue":"5","key":"3352_CR23","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1183\/09031936.00128008","volume":"33","author":"PJ Barnes","year":"2009","unstructured":"Barnes PJ, Celli BR. Systemic manifestations and comorbidities of COPD. Eur Respir J. 2009;33(5):1165\u201385. https:\/\/doi.org\/10.1183\/09031936.00128008.","journal-title":"Eur Respir J"},{"issue":"6","key":"3352_CR24","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1056\/NEJM199902113400607","volume":"340","author":"C Gabay","year":"1999","unstructured":"Gabay C, Kushner I. Acute-phase proteins and other systemic responses to inflammation. N Engl J Med. 1999;340(6):448\u201354. https:\/\/doi.org\/10.1056\/NEJM199902113400607.","journal-title":"N Engl J Med"},{"issue":"3","key":"3352_CR25","doi-asserted-by":"publisher","first-page":"E80","DOI":"10.3390\/biom8030080","volume":"8","author":"Y Zhu","year":"2018","unstructured":"Zhu Y, Xian X, Wang Z, et al. Research Progress on the relationship between atherosclerosis and inflammation. Biomolecules. 2018;8(3):E80. https:\/\/doi.org\/10.3390\/biom8030080.","journal-title":"Biomolecules"},{"issue":"8","key":"3352_CR26","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1016\/j.hlc.2015.01.019","volume":"24","author":"M Ka\u017amierczak","year":"2015","unstructured":"Ka\u017amierczak M, Ciebiada M, P\u0119kala-Wojciechowska A, Paw\u0142owski M, Nielepkowicz-Go\u017adzi\u0144ska A, Antczak A. Evaluation of markers of inflammation and oxidative stress in COPD patients with or without Cardiovascular Comorbidities. Heart Lung Circ. 2015;24(8):817\u201323. https:\/\/doi.org\/10.1016\/j.hlc.2015.01.019.","journal-title":"Heart Lung Circ"},{"issue":"3","key":"3352_CR27","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1161\/01.atv.21.3.452","volume":"21","author":"P Lind","year":"2001","unstructured":"Lind P, Hedblad B, Stavenow L, Janzon L, Eriksson KF, Lindg\u00e4rde F. Influence of plasma fibrinogen levels on the incidence of myocardial infarction and death is modified by other inflammation-sensitive proteins: a long-term cohort study. Arterioscler Thromb Vasc Biol. 2001;21(3):452\u20138. https:\/\/doi.org\/10.1161\/01.atv.21.3.452.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"14","key":"3352_CR28","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1056\/NEJM199704033361401","volume":"336","author":"PM Ridker","year":"1997","unstructured":"Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hennekens CH. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med. 1997;336(14):973\u20139. https:\/\/doi.org\/10.1056\/NEJM199704033361401.","journal-title":"N Engl J Med"},{"issue":"9823","key":"3352_CR29","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1016\/S0140-6736(11)60968-9","volume":"379","author":"M Decramer","year":"2012","unstructured":"Decramer M, Janssens W, Miravitlles M. Chronic obstructive pulmonary disease. Lancet. 2012;379(9823):1341\u201351. https:\/\/doi.org\/10.1016\/S0140-6736(11)60968-9.","journal-title":"Lancet"},{"issue":"12","key":"3352_CR30","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1136\/thoraxjnl-2016-209125","volume":"72","author":"M Moualla","year":"2017","unstructured":"Moualla M, Qualls C, Arynchyn A, et al. Rapid decline in lung function is temporally associated with greater metabolically active adiposity in a longitudinal study of healthy adults. Thorax. 2017;72(12):1113\u201320. https:\/\/doi.org\/10.1136\/thoraxjnl-2016-209125.","journal-title":"Thorax"},{"issue":"6","key":"3352_CR31","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1164\/rccm.200807-1195OC","volume":"179","author":"N Leone","year":"2009","unstructured":"Leone N, Courbon D, Thomas F, et al. Lung function impairment and metabolic syndrome: the critical role of abdominal obesity. Am J Respir Crit Care Med. 2009;179(6):509\u201316. https:\/\/doi.org\/10.1164\/rccm.200807-1195OC.","journal-title":"Am J Respir Crit Care Med"},{"issue":"7","key":"3352_CR32","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1136\/thx.2007.088112","volume":"63","author":"AK Johnston","year":"2008","unstructured":"Johnston AK, Mannino DM, Hagan GW, Davis KJ, Kiri VA. Relationship between lung function impairment and incidence or recurrence of cardiovascular events in a middle-aged cohort. Thorax. 2008;63(7):599\u2013605. https:\/\/doi.org\/10.1136\/thx.2007.088112.","journal-title":"Thorax"},{"issue":"24","key":"3352_CR33","doi-asserted-by":"publisher","first-page":"e010672","DOI":"10.1161\/JAHA.118.010672","volume":"7","author":"MJ Cuttica","year":"2018","unstructured":"Cuttica MJ, Colangelo LA, Dransfield MT, et al. Lung function in young adults and risk of Cardiovascular events over 29 years: the CARDIA Study. J Am Heart Assoc. 2018;7(24):e010672. https:\/\/doi.org\/10.1161\/JAHA.118.010672.","journal-title":"J Am Heart Assoc"},{"issue":"4","key":"3352_CR34","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1093\/eurjhf\/hfs016","volume":"14","author":"SK Agarwal","year":"2012","unstructured":"Agarwal SK, Heiss G, Barr RG, et al. Airflow obstruction, lung function, and risk of incident heart failure: the atherosclerosis risk in Communities (ARIC) study. Eur J Heart Fail. 2012;14(4):414\u201322. https:\/\/doi.org\/10.1093\/eurjhf\/hfs016.","journal-title":"Eur J Heart Fail"},{"issue":"2","key":"3352_CR35","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1093\/europace\/eut255","volume":"16","author":"LSB Johnson","year":"2014","unstructured":"Johnson LSB, Juhlin T, Engstr\u00f6m G, Nilsson PM. Reduced forced expiratory volume is associated with increased incidence of atrial fibrillation: the Malmo Preventive Project. Europace. 2014;16(2):182\u20138. https:\/\/doi.org\/10.1093\/europace\/eut255.","journal-title":"Europace"},{"issue":"2","key":"3352_CR36","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.tcm.2019.12.009","volume":"31","author":"SHR Ramalho","year":"2021","unstructured":"Ramalho SHR, Shah AM. Lung function and cardiovascular disease: a link. Trends Cardiovasc Med. 2021;31(2):93\u20138. https:\/\/doi.org\/10.1016\/j.tcm.2019.12.009.","journal-title":"Trends Cardiovasc Med"},{"key":"3352_CR37","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.rmed.2018.10.007","volume":"144","author":"S Zaigham","year":"2018","unstructured":"Zaigham S, Johnson L, Wollmer P, Engstr\u00f6m G. Measures of low lung function and the prediction of incident COPD events and acute coronary events. Respir Med. 2018;144:68\u201373. https:\/\/doi.org\/10.1016\/j.rmed.2018.10.007.","journal-title":"Respir Med"},{"issue":"1","key":"3352_CR38","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1136\/jech-2011-200104","volume":"67","author":"M Mach\u00f3n","year":"2013","unstructured":"Mach\u00f3n M, Arriola L, Larra\u00f1aga N, et al. Validity of self-reported prevalent cases of stroke and acute myocardial infarction in the spanish cohort of the EPIC study. J Epidemiol Community Health. 2013;67(1):71\u20135. https:\/\/doi.org\/10.1136\/jech-2011-200104.","journal-title":"J Epidemiol Community Health"},{"issue":"6","key":"3352_CR39","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1016\/j.jclinepi.2008.07.016","volume":"62","author":"K Yamagishi","year":"2009","unstructured":"Yamagishi K, Ikeda A, Iso H, Inoue M, Tsugane S, JPHC Study Group. Self-reported stroke and myocardial infarction had adequate sensitivity in a population-based prospective study JPHC (Japan Public Health Center)-based prospective study. J Clin Epidemiol. 2009;62(6):667\u201373. https:\/\/doi.org\/10.1016\/j.jclinepi.2008.07.016.","journal-title":"J Clin Epidemiol"},{"issue":"10","key":"3352_CR40","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1016\/j.jclinepi.2004.04.005","volume":"57","author":"Y Okura","year":"2004","unstructured":"Okura Y, Urban LH, Mahoney DW, Jacobsen SJ, Rodeheffer RJ. Agreement between self-report questionnaires and medical record data was substantial for diabetes, hypertension, myocardial infarction and stroke but not for heart failure. J Clin Epidemiol. 2004;57(10):1096\u2013103. https:\/\/doi.org\/10.1016\/j.jclinepi.2004.04.005.","journal-title":"J Clin Epidemiol"},{"issue":"4","key":"3352_CR41","doi-asserted-by":"publisher","first-page":"e001709","DOI":"10.1161\/JAHA.114.001709","volume":"4","author":"NS Shah","year":"2015","unstructured":"Shah NS, Huffman MD, Ning H, Lloyd-Jones DM. Trends in myocardial infarction secondary prevention: the National Health and Nutrition examination surveys (NHANES), 1999\u20132012. J Am Heart Assoc. 2015;4(4):e001709. https:\/\/doi.org\/10.1161\/JAHA.114.001709.","journal-title":"J Am Heart Assoc"},{"key":"3352_CR42","doi-asserted-by":"publisher","first-page":"936926","DOI":"10.3389\/fnut.2022.936926","volume":"9","author":"W Dong","year":"2022","unstructured":"Dong W, Yang Z. Association of Dietary Fiber Intake with myocardial infarction and stroke events in US adults: a cross-sectional study of NHANES 2011\u20132018. Front Nutr. 2022;9:936926. https:\/\/doi.org\/10.3389\/fnut.2022.936926.","journal-title":"Front Nutr"}],"container-title":["BMC Cardiovascular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-023-03352-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12872-023-03352-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-023-03352-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,29]],"date-time":"2023-06-29T13:02:19Z","timestamp":1688043739000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccardiovascdisord.biomedcentral.com\/articles\/10.1186\/s12872-023-03352-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,29]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["3352"],"URL":"https:\/\/doi.org\/10.1186\/s12872-023-03352-2","relation":{},"ISSN":["1471-2261"],"issn-type":[{"value":"1471-2261","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,29]]},"assertion":[{"value":"18 March 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 June 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 June 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The NHANES survey was approved by the Ethics Committee of the National Center for Health Statistics. All signed informed consent and the data used were de-identified. All information from the NHANES program is available and free for public, so the agreement of the medical ethics committee board was not necessary. The study was conducted in accordance with the Declaration of Helsinki (as revised in 2013).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"331"}}